How has OnKure Therapeutics, Inc.'s operating lease liabilities changed year-over-year?

OnKure Therapeutics, Inc.'s operating lease liabilities decreased by 7.7% year-over-year, from -$130K to -$140K.

What is the long-term trend for OnKure Therapeutics, Inc.'s operating lease liabilities?

Over 2 years (2022 to 2025), OnKure Therapeutics, Inc.'s operating lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$437K to -$536K.

OnKure Therapeutics, Inc. OKUR Operating lease liabilities

Operating lease liabilities at other companies

Eikon Therapeutics, Inc. EIKN

——

Inhibrx Biosciences, Inc.INBX

——

Replimune GroupREPL

——

BillionToOne, Inc. BLLN

——

Other financials

Income statement

See full

Revenue-—

Operating income-$15.6M+8.1%

Net income-$15.2M+4.8%

EPS (diluted)-$1.11+6.7%

Balance sheet

See full

Cash & equivalents$192.1M+98.7%

Total debt$409.0K-57.2%

Total equity$184.4M+103%

Total assets$198.7M+98.9%

Cash flow

See full

Operating cash flow-$12.9M+7.6%

CapEx$5.0K-72.2%

Free cash flow-$12.9M+7.7%

Valuation

See full

Market cap$184.2M+72.6%

Enterprise value-$7.49M-127%

Returns & leverage

See full

Return on equity-42.7%—

Debt / equity0×0.0×

Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s operating lease liabilities?: OnKure Therapeutics, Inc. (OKUR) reported operating lease liabilities of -$140K in Q1 2026.
How has OnKure Therapeutics, Inc.'s operating lease liabilities changed year-over-year?: OnKure Therapeutics, Inc.'s operating lease liabilities decreased by 7.7% year-over-year, from -$130K to -$140K.
What is the long-term trend for OnKure Therapeutics, Inc.'s operating lease liabilities?: Over 2 years (2022 to 2025), OnKure Therapeutics, Inc.'s operating lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$437K to -$536K.